[
  {
    "ts": "2025-05-29T20:30:00+00:00",
    "headline": "Danaher Announces Diagnostic Development and Commercialization Partnership to Scale Precision Medicine",
    "summary": "Danaher Corporation (NYSE: DHR) (\"Danaher\"), a global science and technology innovator, announced today the launch of a partnership with AstraZeneca (LSE/STO/Nasdaq: AZN) to develop and commercialize novel diagnostic tools and tests intended to help clinicians better determine which patients would most benefit from precision medicine treatments.",
    "url": "https://finance.yahoo.com/news/danaher-announces-diagnostic-development-commercialization-203000595.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "5e19adac-ac5e-392d-9b72-49420fe6686e",
      "content": {
        "id": "5e19adac-ac5e-392d-9b72-49420fe6686e",
        "contentType": "STORY",
        "title": "Danaher Announces Diagnostic Development and Commercialization Partnership to Scale Precision Medicine",
        "description": "",
        "summary": "Danaher Corporation (NYSE: DHR) (\"Danaher\"), a global science and technology innovator, announced today the launch of a partnership with AstraZeneca (LSE/STO/Nasdaq: AZN) to develop and commercialize novel diagnostic tools and tests intended to help clinicians better determine which patients would most benefit from precision medicine treatments.",
        "pubDate": "2025-05-29T20:30:00Z",
        "displayTime": "2025-05-29T20:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/ab54422a10f405a45d2b5ac63c901aab",
          "originalWidth": 16,
          "originalHeight": 16,
          "caption": "Cision",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/TcC.T7tlWKUrRT.x1piwlQ--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/ab54422a10f405a45d2b5ac63c901aab.cf.webp",
              "width": 16,
              "height": 16,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/EerddEM7gQj87._PyUajmw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/ab54422a10f405a45d2b5ac63c901aab.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/danaher-announces-diagnostic-development-commercialization-203000595.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/danaher-announces-diagnostic-development-commercialization-203000595.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AZN"
            },
            {
              "symbol": "AZNCF"
            },
            {
              "symbol": "DHR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]